# Trial of Liposomal Bupivacaine for TKA

> **NCT05635916** · PHASE4 · COMPLETED · sponsor: **Northern Light Mercy Hospital** · enrollment: 80 (actual)

## Conditions studied

- Knee Replacement
- Total Knee Arthroplasty
- Post-Operative Pain

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT05635916
- **Lead sponsor:** Northern Light Mercy Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-22
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-04-17
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635916, "Trial of Liposomal Bupivacaine for TKA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05635916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*